Horses with recurrent airway obstruction may no longer have to suffer following Food and Drug Administration approval of a specially designed equine inhaler with medication.
Horses with recurrent airway obstruction may no longer have to suffer following Food and Drug Administration approval of a specially designed equine inhaler with medication.
Boehringer-Ingelheim Vetmedica has received the approval for Torpex, which uses albuterol sulfate combined with an equine-specific metered dose inhaler developed by 3m.
The device is expected to be on the market later this spring.
UN, WHO address public health concern over avian flu transmission to humans
April 18th 2024Veterinary professionals working with certain animals are advised to take precautionary steps to minimize risk of infection, while researchers in Texas study potential H5N1 vaccines, antivirals, and antibody therapies for humans
Read More